UW-Madison researchers find Zika virus in Colombia, look for ways to stop it
In October 2015, a team of researchers at the University of Wisconsin—Madison and Universidad de Sucre in Colombia ran the first tests confirming the presence of Zika virus transmission in the South American country.
In a study published today (Jan 26, 2016) in the journal Emerging Infectious Diseases, the team documents a disease trajectory that started with nine positive patients and has now spread to more than 13,000 infected individuals in that country.
Zika virus, which spreads among humans via mosquitoes, causes illness characterized like many other viral infections by fever, rash and joint pain. Officials estimate that four out of five people who contract the virus do not get sick and the virus is rarely fatal. However, pregnant women in Brazil infected with Zika have given birth to babies with small heads and underdeveloped brains, a condition called microcephaly.
“If you’re pregnant or planning on being pregnant, absolutely, cancel your vacation,” says Aliota, echoing the Centers for Disease Control and Prevention warning that pregnant women not travel to the more than 20 countries now known to have active Zika transmission, like Brazil, Colombia, Ecuador and in the Caribbean. In these countries, mosquitoes are spreading the virus to people.
For the Colombian finding, Aliota and his research team, which includes Jorge Osorio, professor of pathobiological sciences at SVM, and two visiting doctoral students from Colombia, tested samples from 22 patients for the genetic fingerprints of Zika, dengue and chikungunya viruses.
Nine came back positive for Zika virus. Now, 13,500 cases have been identified in Colombia. The researchers’ findings highlight the need for better, more accurate laboratory diagnosis of Zika virus.
The symptoms of Zika virus are “really nonspecific and it overlaps with a lot of things, especially with dengue virus and chikungunya,” says Aliota. “It’s hard when someone comes in with a fever and a rash to narrow it down.”
Zika virus was first found in Uganda in 1947 but remained limited to Africa and Southeast Asia for decades. But in 2007, an outbreak occurred in the Pacific Islands and recently the virus began to spread in the Western Hemisphere.
“Historically, Zika virus has just caused mild disease, but as it moved into the New World, in Brazil, we started to notice these more serious consequences associated with it,” says Aliota. “There is a lot that is unknown.”
Aliota hopes to help change that.
His research on Zika virus and others like it is focused on how the viruses evolve and adapt to their hosts, including mosquitoes and humans. As he and the team show in the study, the Zika virus has split into two distinct lineages, African and Asian. The Colombia strain of the virus can be tracked to Brazil, which can be traced to a strain that originated in French Polynesia.
“There is certainly something different about these viruses that have allowed or facilitated this geographic expansion,” Aliota says.
He and Osorio are now looking for ways to control it. As members of the Eliminate Dengue Program, an international effort managed by Monash University in Melbourne, Australia, they have explored how a bacterium that infects 60 percent of insects around the world may be used as a tool to combat the spread of dengue and similar mosquito-borne viruses.
Zika, dengue and chikungunya (which are also found in Colombia) are RNA viruses, which refers to how they encode their genetic material, and each is transmitted by a specific mosquito called Aedes aegypti. The mosquito is common in Colombia and other countries where Zika has become prevalent.
The bacterium, Wolbachia, is not naturally found in the Aedes aegypti mosquito, but researchers with Eliminate Dengue have found that when they infect mosquitoes with the bacteria in the lab, it prevents them from transmitting dengue, chikungunya and yellow fever.
The researchers’ findings highlight the need for better, more accurate laboratory diagnosis of Zika virus.
“The Eliminate Dengue Program is doing field experiments to see, will we be able to replace wild-type, existing populations of mosquitoes with these Wolbachia-infected ones and does it block dengue transmission?” Aliota says. “Now, we’re going to start looking at how that might be used for Zika virus control as well in South America.”
Here in Madison, Aliota is also trying to better understand how these viruses might evolve and adapt to this potential control strategy, to try to stay ahead of any potential issues they might encounter in the field.
But while Texas and Florida need to be on alert, Aliota says Wisconsinites need not be worried about transmission of Zika virus here.
“We’re not going to get Zika transmission in Wisconsin. We don’t have Aedes aegypti,” he says. “The cold winters are good for something.”